Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123711902 | 12371190 | 2 | F | 20150912 | 20160624 | 20160516 | 20160704 | EXP | US-009507513-1605USA006406 | MERCK | 59.00 | YR | F | Y | 74.97000 | KG | 20160704 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123711902 | 12371190 | 1 | PS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 50-1000 MG, BID | U | 22044 | FILM-COATED TABLET | BID | |||||||
| 123711902 | 12371190 | 2 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 2 DF, Q4H (PRN) | U | 0 | 2 | DF | Q4H | ||||||
| 123711902 | 12371190 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | TABLET | QD | |||||
| 123711902 | 12371190 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, QD | U | 0 | 40 | MG | QD | |||||||
| 123711902 | 12371190 | 5 | C | CALCIUM (UNSPECIFIED) | CALCIUM | 1 | UNK | U | 0 | ||||||||||
| 123711902 | 12371190 | 6 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 5 MG, TID (PRN) | U | 0 | 5 | MG | TID | ||||||
| 123711902 | 12371190 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 123711902 | 12371190 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0.125 MG, QD | U | 0 | QD | ||||||||
| 123711902 | 12371190 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 123711902 | 12371190 | 10 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 400 MG, BID | U | 0 | 400 | MG | BID | ||||||
| 123711902 | 12371190 | 11 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | U | 0 | BID | ||||||||
| 123711902 | 12371190 | 12 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 15 MG, QD | U | 0 | 15 | MG | QD | ||||||
| 123711902 | 12371190 | 13 | C | ACIPHEX | RABEPRAZOLE SODIUM | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | BID | ||||||
| 123711902 | 12371190 | 14 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | UNK | U | 0 | FILM-COATED TABLET | |||||||||
| 123711902 | 12371190 | 15 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75/37.5 MG, QD | U | 0 | QD | ||||||||
| 123711902 | 12371190 | 16 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 123711902 | 12371190 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123711902 | 12371190 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123711902 | 12371190 | Pancreatitis acute | |
| 123711902 | 12371190 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123711902 | 12371190 | 1 | 2011 | 0 |